| Dr Thomas G Sternberg, MD | |
|
2724 Nashville Rd, Bowling Green, KY 42101-4000 | |
| (270) 780-0560 | |
| (270) 780-0467 |
| Full Name | Dr Thomas G Sternberg |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 24 Years |
| Location | 2724 Nashville Rd, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467448175 | NPI | - | NPPES |
| 7100077590 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 42661 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gilbert Barbee Moore And Mcilvoy Psc | 4082511167 | 223 |
News Archive
PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.
TrialReach, the world's largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. With one of the biggest digital health rounds ever raised in the United Kingdom, TrialReach plans to use the funds to support the growth of its clinical trial platform and expansion into the U.S..
One New Jersey nonprofit is bucking the trend of skyrocketing health insurance costs while Congress wrangles with health care reform. Through an entrepreneurial business model, self-insurance and the use of a Voluntary Employee Benefits Association (VEBA), Community Access Unlimited (CAU) has limited increases in health insurance costs to just 3.3 percent in each of the last five years and saved more than $1 million during that time. CAU will have a 0.0 percent increase in 2010 and will expand coverage.
Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced the completion of a $40 million Series D financing.
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) than white patients and that poor HR-QoL resulted in shorter median survival.
› Verified 5 days ago
| Entity Name | Gilbert Barbee Moore & Mcilvoy Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114948288 PECOS PAC ID: 4082511167 Enrollment ID: O20031217000136 |
News Archive
PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.
TrialReach, the world's largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. With one of the biggest digital health rounds ever raised in the United Kingdom, TrialReach plans to use the funds to support the growth of its clinical trial platform and expansion into the U.S..
One New Jersey nonprofit is bucking the trend of skyrocketing health insurance costs while Congress wrangles with health care reform. Through an entrepreneurial business model, self-insurance and the use of a Voluntary Employee Benefits Association (VEBA), Community Access Unlimited (CAU) has limited increases in health insurance costs to just 3.3 percent in each of the last five years and saved more than $1 million during that time. CAU will have a 0.0 percent increase in 2010 and will expand coverage.
Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced the completion of a $40 million Series D financing.
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) than white patients and that poor HR-QoL resulted in shorter median survival.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas G Sternberg, MD 201 Park St, Bowling Green, KY 42101-1708 Ph: (270) 780-0560 | Dr Thomas G Sternberg, MD 2724 Nashville Rd, Bowling Green, KY 42101-4000 Ph: (270) 780-0560 |
News Archive
PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.
TrialReach, the world's largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. With one of the biggest digital health rounds ever raised in the United Kingdom, TrialReach plans to use the funds to support the growth of its clinical trial platform and expansion into the U.S..
One New Jersey nonprofit is bucking the trend of skyrocketing health insurance costs while Congress wrangles with health care reform. Through an entrepreneurial business model, self-insurance and the use of a Voluntary Employee Benefits Association (VEBA), Community Access Unlimited (CAU) has limited increases in health insurance costs to just 3.3 percent in each of the last five years and saved more than $1 million during that time. CAU will have a 0.0 percent increase in 2010 and will expand coverage.
Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced the completion of a $40 million Series D financing.
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that Hispanics and blacks had a higher burden of poor health-related quality-of-life (HR-QoL) than white patients and that poor HR-QoL resulted in shorter median survival.
› Verified 5 days ago
Kourtney G. Gardner, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 | |
Dr. Jonathon Baldwin, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1724 Rockingham Ave, Suite 101, Bowling Green, KY 42104 Phone: 270-842-7588 Fax: 270-842-7687 | |
James R Parkerson, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 | |
Dr. Patricia Mercer, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2724 Nashville Rd, Bowling Green, KY 42101 Phone: 270-780-0560 Fax: 270-780-0467 | |
Dr. Diana K Cavanah, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 201 Park St, Bowling Green, KY 42101 Phone: 270-781-5111 Fax: 270-780-0467 | |
Dr. Indar Mohan Jhamb, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1217 Ashley Cir, Bowling Green, KY 42104 Phone: 270-782-3237 Fax: 270-782-1412 |